Napredna pretraga

Pregled bibliografske jedinice broj: 1006975

Optimization of an ex vivo gene transfer to the hamstrings tendons muscle remnants: potential for genetic enhancement of bone healing


Rod, Eduard; Matić, igor; Antunović, Maja; Vetma, Vesna; Pavičić, Ivan; Hudetz, Damir; Marijanović, Inga; Primorac, Dragan; Ivković, Alan
Optimization of an ex vivo gene transfer to the hamstrings tendons muscle remnants: potential for genetic enhancement of bone healing // Croatian medical journal, 60 (2019), 201-211 doi:10.3325/cmj.2019.60.201 (međunarodna recenzija, članak, znanstveni)


Naslov
Optimization of an ex vivo gene transfer to the hamstrings tendons muscle remnants: potential for genetic enhancement of bone healing

Autori
Rod, Eduard ; Matić, igor ; Antunović, Maja ; Vetma, Vesna ; Pavičić, Ivan ; Hudetz, Damir ; Marijanović, Inga ; Primorac, Dragan ; Ivković, Alan

Izvornik
Croatian medical journal (0353-9504) 60 (2019); 201-211

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Ad.BMP-2 ; human muscle tissue ; anterior cruciate ligament reconstructions ; osteogenic differentiation

Sažetak
Aim To assess whether an adenoviral vector carrying the bone morphogenetic protein genes (Ad.BMP-2) can trans-duce human muscle tissue and direct it toward osteogenic differentiation within one hour. Methods This in vitro study, performed at the Department of Molecular Biology, Faculty of Science, Zagreb from 2012 to 2017, used human muscle tissue samples collected during anterior cruciate ligament reconstructions performed in St Catherine Hospital, Zabok. Samples from 28 patients were transduced with adenoviral vector carrying firefly luciferase cDNA (Ad.luc) by using different doses and times of transduction, and with addition of positive ions for transduction enhancement. The optimized protocol was further tested on muscle samples from three new patients, which were transduced with Ad.BMP-2. Released bone morphogenetic protein 2 (BMP-2) levels in osteogenic medium were measured every three days during a period of 21 days. Expression of osteogenic markers was measured at day 14 and 21. After 21 days of cultivation, muscle tissue was immunohistochemically stained for collagen type I detection (COL-I). Results The new transduction protocol was established using 108 plaque-forming units (P < 0.001) as an optimal dose of adenoviral vector and 30 minutes (P < 0.001) as an opti-mal contact time. Positive ions did not enhance transduction. Samples transduced with Ad.BMP-2 according to the optimized protocol showed enhanced expression of osteogenic markers (P < 0.050), BMP-2 (P < 0.001), and COL I. Conclusion This study confirms that Ad.BMP-2 can transduce human muscle tissue and direct it toward osteogenic differentiation within 30 minutes.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove
Institut za medicinska istraživanja i medicinu rada, Zagreb,
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
Prirodoslovno-matematički fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
Medicinski fakultet, Split,
Medicinski fakultet, Osijek,
Dječja bolnica Srebrnjak,
Sveučilište u Rijeci - Odjel za biotehnologiju,
Specijalna bolnica Sv. Katarina

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati